MedTrace Logo

Exploration of Sensory-motor Representations in Children of Typical Development Aged 5 to 8

NCT05300100 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-03-24

No results posted yet for this study

Summary

Evaluate the quality of sensorimotor representations in typically developing children aged 5 to 8 years.

Conditions

  • CHILD

Interventions

BEHAVIORAL

sensorimotor activities

The activities chosen involve either the whole body or specific parts such as the hand to grasp or perform graphic tests. * Trial 1 : Straightening: passage from sitting to sitting. * Trial 2 : Movement with difficulty of balance: heel-toe walking * Trial 3 : Movement with difficulty of balance with a structured visual environment: heel-toe walk in a contrasting fabric decoration to increase the impact of visual flow * Trial 4 : Move to a target, 5 m away * Trial 5 : Graphics: drawing of a tree. This test requires spatial skills and the establishment of median space in written transcription. * Trial 6 : Manual entry: collection of 12 small cubes arranged in an arc in front of the child using one hand, the choice of which will be left to the child. All of these tests will be offered according to a so-called "interlaced" protocol, that is to say, each execution of an action will be followed by an action simulation, and this alternation will be repeated 5 times for each task. .

Sponsors & Collaborators

  • Centre National de la Recherche Scientifique, France

    collaborator OTHER

  • Centre Hospitalier de Lens

    lead OTHER

Principal Investigators

  • Marie-Bertille DEHOUCK, Dr · Hospital of Lens

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-04
Primary Completion
2023-01-27
Completion
2023-01-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05300100 on ClinicalTrials.gov